|
End-of-day quote
NSE India S.E.
2026-10-19
|
5-day change | 1st Jan Change | ||
| 1,766.60 INR | -2.97% |
|
-5.40% | +29.47% |
| Market Cap | 335B 3.53B 3.15B 2.92B 2.65B 4.98B 5.06B 35B 13.76B 175B 13.26B 12.98B 560B | P/E 2027 * |
28.2x | P/E 2028 * | 23x |
|---|---|---|---|---|---|
| Enterprise Value | 341B 3.6B 3.21B 2.97B 2.7B 5.07B 5.16B 35.67B 14.03B 178B 13.51B 13.23B 571B | EV / Sales 2027 * |
3.22x | EV / Sales 2028 * | 2.78x |
| Free-Float |
22.18% | Yield 2027 * |
0.23% | Yield 2028 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| EMCURE | End-of-day quote | |
Bombay S.E.
| EMCURE | Delayed |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | -2.97% | ||
| 1 week | -5.40% | ||
| Current month | -9.08% | ||
| 1 month | -11.84% | ||
| 3 months | -0.93% | ||
| 6 months | +5.65% | ||
| Current year | +29.47% |
| 1 week | 1,746.5 |  | 1,887.9 |
| 1 month | 1,746.5 | | 2,045 |
| Current year | 1,381 | | 2,100.7 |
| 1 year | 1,306.5 | | 2,100.7 |
| 3 years | 889 | | 2,100.7 |
| 5 years | 889 | | 2,100.7 |
| 10 years | 889 | | 2,100.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 1981-04-15 | |
| Director of Finance/CFO | - | 2003-09-30 | |
| Compliance Officer | - | 2026-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 2001-07-22 | |
| Chairman | 75 | 2026-09-20 | |
| Director/Board Member | 72 | 2021-04-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.97% | -5.40% | +31.10% | - | 3.64B | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,120B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 616B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 504B | |
| +0.24% | +5.58% | +33.98% | +59.40% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 360B | |
| -0.40% | +3.53% | +19.17% | +46.55% | 288B | |
| -0.37% | +3.11% | -1.26% | +18.23% | 258B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 234B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 194B | |
| Average | -1.18% | +1.53% | +32.82% | +64.95% | 394.45B | |
| Weighted average by Cap. | -0.99% | +2.42% | +37.89% | +75.52% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 106B 1.12B 997M 924M 840M 1.58B 1.6B 11.08B 4.36B 55.43B 4.2B 4.11B 177B | 119B 1.26B 1.12B 1.04B 946M 1.78B 1.8B 12.48B 4.91B 62.45B 4.73B 4.63B 200B |
| Net income | 11.89B 125M 112M 104M 94.19M 177M 180M 1.24B 489M 6.22B 471M 461M 19.87B | 14.54B 153M 137M 127M 115M 216M 220M 1.52B 597M 7.6B 576M 564M 24.3B |
| Net Debt | 6.38B 67.34M 60.02M 55.6M 50.56M 94.87M 96.43M 667M 262M 3.34B 253M 247M 10.67B | -3.28B -34.58M -30.82M -28.55M -25.96M -48.71M -49.51M -342M -135M -1.71B -130M -127M -5.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | ₹1,766.60 | -2.97% | 108,214 |
| 26-10-16 | ₹1,820.60 | -0.84% | 39,565 |
| 26-10-15 | ₹1,836.00 | -1.62% | 66,977 |
| 26-10-14 | ₹1,866.20 | -0.13% | 157,573 |
| 26-10-13 | ₹1,868.60 | +0.06% | 55,653 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
